Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback